International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency.

[1]  K. Kragballe,et al.  Hereditary Angioedema. , 2018, The New England journal of medicine.

[2]  Jay L. Martello,et al.  Ecallantide for treatment of acute attacks of hereditary angioedema. , 2012, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[3]  B. Chipps.  Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema , 2011, Pediatrics.

[4]  J. Piette,et al.  Pregnane progestin contraception in systemic lupus erythematosus: a longitudinal study of 187 patients. , 2011, Contraception.

[5]  R. Bautista-Llácer,et al.  Case report: first successful application of preimplantation genetic diagnosis for hereditary angiooedema. , 2010, Reproductive biomedicine online.

[6]  Tranexamic Acid (Lysteda) for Treatment of Menorrhagia , 2010, The Medical letter on drugs and therapeutics.

[7]  J. Nuijens,et al.  Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. , 2010, The Journal of allergy and clinical immunology.

[8]  H. Farkas,et al.  The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: a long-term survey. , 2010, European journal of obstetrics, gynecology, and reproductive biology.

[9]  B. Zuraw.  The Pathophysiology of Hereditary Angioedema , 2010, The World Allergy Organization journal.

[10]  William H. Yang,et al.  Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. , 2010, The New England journal of medicine.

[11]  T. Klingebiel,et al.  Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate. , 2010, American journal of obstetrics and gynecology.

[12]  P. Keith,et al.  2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[13]  M. Gompels,et al.  HAE international home therapy consensus document , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[14]  E. Papanikolaou,et al.  Preventing ovarian hyperstimulation syndrome: guidance for the clinician. , 2010, Fertility and sterility.

[15]  M. Maurer,et al.  Erfolgreiche Behandlung des hereditären Angioödems mit dem Bradykinin‐B2‐Rezeptor‐Antagonisten Icatibant , 2010 .

[16]  H. Farkas,et al.  The effect of long-term danazol prophylaxis on liver function in hereditary angioedema—a longitudinal study , 2010, European Journal of Clinical Pharmacology.

[17]  J. Bernstein,et al.  Ecallantide: its pharmacology, pharmacokinetics, clinical efficacy and tolerability , 2010, Expert review of clinical immunology.

[18]  J. Bellver,et al.  Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome. , 2009, Fertility and sterility.

[19]  A. Bygum,et al.  Hereditary angio‐oedema in Denmark: a nationwide survey , 2009, The British journal of dermatology.

[20]  P. Haentjens,et al.  Cumulative reproductive outcome after preimplantation genetic diagnosis: a report on 1498 couples. , 2009, Human reproduction.

[21]  J. Bernstein,et al.  Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. , 2009, The Journal of allergy and clinical immunology.

[22]  Christine A. Lee,et al.  The obstetric experience of women with factor XI deficiency , 2009, Acta obstetricia et gynecologica Scandinavica.

[23]  T. Zuberbier,et al.  Successful treatment of hereditary angioedema with bradykinin B2‐receptor antagonist icatibant , 2009, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[24]  J. Thalabard,et al.  Tamoxifen contraindicated in women with hereditary angioedema? , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  K. Sathishkumar,et al.  Elevated Androgen Levels During Pregnancy Impair Fetal Growth Due to Placental Insufficiency and Programs for Adult Hypertension in Rats. , 2009 .

[26]  L. Nardo,et al.  Symposium--Update on prediction and management of OHSS: introduction to guest symposium. , 2009, Reproductive biomedicine online.

[27]  W. Chan.  The ‘ART’ of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology , 2009, Current opinion in obstetrics & gynecology.

[28]  P. Borry.  Genetic testing in asymptomatic minors: recommendations of the European Society of Human Genetics , 2009, European Journal of Human Genetics.

[29]  Julie Brown,et al.  Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. , 2009, The Cochrane database of systematic reviews.

[30]  A. Szema,et al.  Modern preoperative and intraoperative management of hereditary angioedema. , 2009, Allergy and asthma proceedings.

[31]  C. Katelaris,et al.  Hereditary angioedema and pregnancy , 2009, The Australian & New Zealand journal of obstetrics & gynaecology.

[32]  H. Farkas,et al.  Disease expression in women with hereditary angioedema. , 2008, American journal of obstetrics and gynecology.

[33]  P. Sanhueza.  Contraception in hereditary angioedema. , 2008, Fertility and sterility.

[34]  T. Craig,et al.  Treatment of hereditary angioedema with plasma-derived C1 inhibitor , 2008, Therapeutics and clinical risk management.

[35]  A. Tordai,et al.  Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: functional and structural correlates. , 2008, Molecular immunology.

[36]  L. Lantieri,et al.  Peut-on proposer un acte de chirurgie esthétique à un(e) patient(e) atteint(e) d’un œdème angioneurotique ? , 2008 .

[37]  K. Bork,et al.  [Contraception and pregnancy in hereditary angioedema]. , 2008, Deutsche medizinische Wochenschrift.

[38]  P. Gorman.  Hereditary angioedema and pregnancy: a successful outcome using C1 esterase inhibitor concentrate. , 2008, Canadian family physician Medecin de famille canadien.

[39]  H. Longhurst.  Rhucin, a recombinant C1 inhibitor for the treatment of hereditary angioedema and cerebral ischemia. , 2008, Current opinion in investigational drugs.

[40]  K. Bork,et al.  Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[41]  M. Frank.  8. Hereditary angioedema. , 2008, The Journal of allergy and clinical immunology.

[42]  H. Farkas,et al.  Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy. , 2007, The Journal of allergy and clinical immunology.

[43]  R. Kimmig,et al.  Expression and regulation of estrogen-converting enzymes in ectopic human endometrial tissue. , 2007, Fertility and sterility.

[44]  H. Farkas,et al.  Management of Hereditary Angioedema in Pediatric Patients , 2007, Pediatrics.

[45]  A. Sheffer,et al.  Hereditary angioedema: Safety of long-term stanozolol therapy. , 2007, The Journal of allergy and clinical immunology.

[46]  Lynda Schneider,et al.  Critical role of kallikrein in hereditary angioedema pathogenesis: a clinical trial of ecallantide, a novel kallikrein inhibitor. , 2007, The Journal of allergy and clinical immunology.

[47]  H. Schuitemaker,et al.  Viral safety of C1-inhibitor NF. , 2007, Biologicals : journal of the International Association of Biological Standardization.

[48]  H. Farkas,et al.  Recombinant human C1‐inhibitor in the treatment of acute angioedema attacks , 2007, Transfusion.

[49]  P. Schlattmann,et al.  Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). , 2007, The Journal of allergy and clinical immunology.

[50]  T. Craig,et al.  Fresh frozen plasma for the treatment of hereditary angioedema. , 2007, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[51]  A. Rubbert,et al.  Treatment of hereditary angioneurotic oedema (HANE) with tibolone , 2007, Clinical endocrinology.

[52]  G. Kojda,et al.  Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2‐receptor antagonist icatibant , 2006, Allergy.

[53]  J. Levy,et al.  The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema , 2006, Expert opinion on investigational drugs.

[54]  T. Kasai,et al.  Danazol inhibits aromatase activity of endometriosis-derived stromal cells by a competitive mechanism. , 2006, Fertility and sterility.

[55]  C. Weiler,et al.  Genetic test indications and interpretations in patients with hereditary angioedema. , 2006, Mayo Clinic proceedings.

[56]  J. Sloan,et al.  Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  K. Bork,et al.  Hereditary angioedema: new findings concerning symptoms, affected organs, and course. , 2006, The American journal of medicine.

[58]  K. Bork,et al.  Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema , 2005, Transfusion.

[59]  H. Longhurst.  Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: what is the evidence? , 2005, International journal of clinical practice.

[60]  M. López-Trascasa,et al.  Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. , 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[61]  M. Gompels,et al.  C1 inhibitor deficiency: consensus document , 2005, Clinical and experimental immunology.

[62]  J. Thalabard,et al.  Progestogen-only contraception in women at high risk of venous thromboembolism. , 2004, Contraception.

[63]  A. Tordai,et al.  Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond , 2004, Journal of Allergy and Clinical Immunology.

[64]  V. Frémeaux-Bacchi,et al.  Hereditary angio‐oedema: effective treatment with the progestogen‐only pill in a young woman , 2004, The British journal of dermatology.

[65]  H. Farkas,et al.  Sex hormones in hereditary angioneurotic oedema , 2004, Clinical endocrinology.

[66]  Morton B. Brown,et al.  Fetal programming: prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep. , 2004, Endocrinology.

[67]  A. Schindler.  Differential effects of progestins on hemostasis. , 2003, Maturitas.

[68]  A. Tordai,et al.  Mutation screening of the C1 inhibitor gene among Hungarian patients with hereditary angioedema , 2003, Human mutation.

[69]  K. Bork,et al.  Sudden upper airway obstruction in patients with hereditary angioedema. , 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[70]  William H. Yang,et al.  Management of hereditary angioedema: a Canadian approach. , 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[71]  J. Lindner,et al.  Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert® P) in hereditary angioedema: a review , 2003 .

[72]  K. Christensen,et al.  Positive impact of hormone replacement therapy on the fibrinolytic system: a long‐term randomized controlled study in healthy postmenopausal women , 2003, Journal of thrombosis and haemostasis : JTH.

[73]  K. Bork,et al.  Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. , 2003, Archives of internal medicine.

[74]  M. Cicardi,et al.  Bradykinin and the pathophysiology of angioedema. , 2003, International immunopharmacology.

[75]  K. Bork,et al.  Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. , 2003, The American journal of medicine.

[76]  J. Kitawaki,et al.  Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas. , 2003, Fertility and sterility.

[77]  K. Bork,et al.  Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema. , 2002, Journal of hepatology.

[78]  A. Sheffer,et al.  Episodic swelling in a pregnant woman from Bangladesh: evaluation and management of angioedema in pregnancy. , 2002, Allergy and asthma proceedings.

[79]  N. Shahidi.  A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids. , 2001, Clinical therapeutics.

[80]  M. Kurabayashi,et al.  Effect of long-term hormone replacement therapy on angiotensin-converting enzyme activity and bradykinin in postmenopausal women with essential hypertension and normotensive postmenopausal women , 2001, Menopause.

[81]  D. Mccluskey,et al.  Hereditary angioedema precipitated by estrogen replacement therapy in a menopausal woman. , 2000, The American journal of the medical sciences.

[82]  H. Teede,et al.  Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[83]  D. Mccluskey,et al.  Life-threatening laryngeal oedema in a pregnant woman with hereditary angioedema. , 2000, The Ulster medical journal.

[84]  K. Bork,et al.  Asphyxiation by laryngeal edema in patients with hereditary angioedema. , 2000, Mayo Clinic proceedings.

[85]  L. Brinton,et al.  Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix. , 2000, Gynecologic oncology.

[86]  Fontana,et al.  Impaired Human Ovarian Follicular Fluid Complement Function in Hereditary Angioedema , 2000, Scandinavian journal of immunology.

[87]  M. Cicardi,et al.  Local bradykinin generation in hereditary angioedema. , 1999, The Journal of allergy and clinical immunology.

[88]  K. Bork,et al.  Hepatocellular adenomas in patients taking danazol for here ditary angiooedema , 1999, The Lancet.

[89]  C. Létoublon,et al.  Danazol therapy: an unusual aetiology of hepatocellular carcinoma. , 1998, Journal of hepatology.

[90]  M. Cicardi,et al.  Plasma bradykinin in angio-oedema , 1998, The Lancet.

[91]  A. Fletcher,et al.  Coexistence of hereditary angioedema and Turner's syndrome. , 1998, Postgraduate medical journal.

[92]  R. Pumphrey,et al.  Termination of pregnancy in a patient with hereditary angioedema. , 1997, British journal of hospital medicine.

[93]  C. Lundsteen,et al.  Randomised study of risk of fetal loss related to early amniocentesis versus chorionic villus sampling , 1997, The Lancet.

[94]  M. Cicardi,et al.  Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. , 1997, The Journal of allergy and clinical immunology.

[95]  H. Bürgi,et al.  Type I hereditary angio‐oedema. Variability of clinical presentation and course within two large kindreds , 1997, Journal of internal medicine.

[96]  A. Aribarg,et al.  Suppression of spermatogenesis by testosterone enanthate in Thai men. , 1996, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[97]  H. Galan,et al.  Fresh frozen plasma prophylaxis for hereditary angioedema during pregnancy. A case report. , 1996, The Journal of reproductive medicine.

[98]  S. Misiti,et al.  Estrogen induction and contact phase activation of human factor XII , 1996, Steroids.

[99]  J. Gran,et al.  Hereditary angio‐oedema: new clinical observations and autoimmune screening, complement and kallikrein‐kinin analyses , 1996, Journal of internal medicine.

[100]  U. P. S. T. Force.  Guide to Clinical Preventive Services: Report of the U S Preventive Services Task Force , 1996 .

[101]  A. Gompel.  [Contraceptions in women with contra-indication to estrogen-progestins]. , 1995, La Revue du praticien.

[102]  A. Holdcroft,et al.  Hereditary angioneurotic oedema: current management in pregnancy , 1995, Anaesthesia.

[103]  R. Brown,et al.  Danazol prophylaxis for delivery in hereditary angioneurotic oedema , 1994, British journal of obstetrics and gynaecology.

[104]  T. Mollnes,et al.  C1 Inhibitor and Diagnosis of Hereditary Angioedema in Newborns , 1994, Pediatric Research.

[105]  I. Mackie,et al.  Contact factor mediated fibrinolysis is increased by the combined oral contraceptive pill , 1993, British journal of obstetrics and gynaecology.

[106]  R. Perricone,et al.  Cystic ovaries in women affected with hereditary angioedema , 1992, Clinical and experimental immunology.

[107]  S. Tarlo,et al.  C1 esterase inhibitor in pregnancy. , 1992, The Journal of allergy and clinical immunology.

[108]  M. Cicardi,et al.  Hereditary and Acquired C1‐Inhibitor Deficiency: Biological and Clinical Characteristics in 235 Patients , 1992, Medicine.

[109]  S. Wessler,et al.  Estrogen-associated thromboembolism. , 1992, Annals of epidemiology.

[110]  L. Chao,et al.  Differential regulation of kininogen gene expression by estrogen and progesterone in vivo. , 1992, Biochimica et biophysica acta.

[111]  W. Cunliffe,et al.  HORMONALLY EXACERBATED HEREDITARY ANGIOEDEMA , 1992, The Australasian journal of dermatology.

[112]  N. Hoem,et al.  Contact activation factors in plasma from women using oral contraceptives--increased levels of factor XII, kinin-free high molecular weight kininogen and acetone-activated kallikrein. , 1991, Thrombosis research.

[113]  E. Hack,et al.  Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience. , 1991, The Journal of allergy and clinical immunology.

[114]  M. Frank,et al.  Oral manifestations and dental management of patients with hereditary angioedema. , 1991, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[115]  J. Hardie,et al.  Potentially fatal hereditary angioedema: a review and case report. , 1990, Journal.

[116]  M. Frank,et al.  The long-term safety of danazol in women with hereditary angioedema. , 1990, Fertility and sterility.

[117]  J. A. Grant,et al.  Hereditary angioedema: its diagnostic and management perspectives. , 1990, The American journal of medicine.

[118]  D. Cumming.  Use of spironolactone in treatment of hirsutism. , 1990, Cleveland Clinic journal of medicine.

[119]  R. Lehner,et al.  Recurrent angioedema associated with hypogonadism or anti-androgen therapy. , 1989, Annals of allergy.

[120]  W. Dmowski.  Danazol-induced Pseudomenopause in the Management of Endometriosis , 1988, Clinical obstetrics and gynecology.

[121]  M. Swiet,et al.  Hereditary angioneurotic oedema and pregnancy. Case reports and review of the literature , 1988, British journal of obstetrics and gynaecology.

[122]  G. Lagrue,et al.  [Hereditary angioneurotic edema: norgestrienone is not effective in every case]. , 1987, Presse medicale.

[123]  A. Sheffer,et al.  Hereditary angioedema: a decade of management with stanozolol. , 1987, The Journal of allergy and clinical immunology.

[124]  P. Serhal,et al.  INTRAUTERINE INSEMINATION , 1987, The Lancet.

[125]  Wautier Jl,et al.  [Norgestrienone, a possible therapeutic agent in hereditary angioneurotic edema]. , 1986 .

[126]  J. Douglas,et al.  The influence of estrogen and prolactin on Hageman factor (factor XII) titer in ovariectomized and hypophysectomized rats. , 1985, Blood.

[127]  M. Alen,et al.  Response of serum hormones to androgen administration in power athletes. , 1985, Medicine and science in sports and exercise.

[128]  G. Candiani,et al.  FEMALE PSEUDOHERMAPHRODITISM DUE TO MATERNAL ANDROGEN ADMINISTRATION: 25-YEAR FOLLOW-UP , 1985, The Lancet.

[129]  M. Greaves,et al.  Hereditary Angio-Oedema: Treatment with Cl Esterase Inhibitor Concentrate , 1984, Journal of the Royal Society of Medicine.

[130]  Stiller Rj,et al.  Hereditary angioedema and pregnancy. , 1984 .

[131]  P. Lundborg,et al.  Drug use During Pregnancy and Breast‐Feeding: A classification sytem for drug information , 1984, Acta obstetricia et gynecologica Scandinavica. Supplement.

[132]  G. Viale,et al.  Morphologic evaluation of the liver in hereditary angioedema patients on long-term treatment with androgen derivatives. , 1983, The Journal of allergy and clinical immunology.

[133]  V. Donaldson.  The challenge of hereditary angioneurotic edema. , 1983, The New England journal of medicine.

[134]  D. Ogston,et al.  Blood levels of proteinase inhibitors in pregnancy , 1982, British journal of obstetrics and gynaecology.

[135]  A. Michael,et al.  Influence of age and sex on serum complement components in children. , 1981, American journal of diseases of children.

[136]  A. Sheffer,et al.  Clinical and biochemical effects of stanozolol therapy for hereditary angioedema. , 1981, The Journal of allergy and clinical immunology.

[137]  D. Ogston,et al.  C1 inactivator level in pregnancy. , 1981, Thrombosis research.

[138]  S. Duck,et al.  Danazol may cause female pseudohermaphroditism. , 1981, Fertility and sterility.

[139]  E. Brown,et al.  Long-term therapy of hereditary angioedema with danazol. , 1980, Annals of internal medicine.

[140]  O. Ratnoff,et al.  Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives. , 1980, The Journal of laboratory and clinical medicine.

[141]  G. O. Potts,et al.  Pharmacology and Pharmacokinetics of Danazol , 1980, Drugs.

[142]  M. Frank,et al.  Danazol in the Treatment of Hereditary Angioedema , 1980, Drugs.

[143]  J. Gelfand,et al.  Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor. , 1980, The New England journal of medicine.

[144]  E. Vallota,et al.  Serum Complement Levels in Infancy: Age Related Changes , 1979, Pediatric Research.

[145]  K. Pritzker,et al.  Hereditary angioneurotic edema: an unusual case of maternal mortality. , 1979, Journal of forensic sciences.

[146]  D. Alling,et al.  Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. , 1976, The New England journal of medicine.

[147]  J. Atkinson,et al.  Hereditary angioedema: the clinical syndrome and its management. , 1976, Annals of internal medicine.

[148]  A. Sheffer,et al.  Tranexamic acid therapy in hereditary angioneurotic edema. , 1972, The New England journal of medicine.

[149]  R. Harris.  Organ exchange and tissue typing. , 1970, Lancet.

[150]  S. Kullander,et al.  Human Placental Transfer of an Antifibrinolytic Agent (AMCA) , 1970, Acta obstetricia et gynecologica Scandinavica.

[151]  F. Rosen,et al.  Hereditary angioneurotic edema: a clinical survey. , 1966, Pediatrics.

[152]  F. Rosen,et al.  Hereditary Angioneurotic Edema: Two Genetic Variants , 1965, Science.

[153]  A. Golan,et al.  Symposium: Update on prediction and management of OHSS. A modern classification of OHSS. , 2009, Reproductive biomedicine online.

[154]  A. Golan,et al.  A modern classification of OHSS , 2009 .

[155]  William H. Yang,et al.  Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[156]  A. Sheffer,et al.  Hereditary angioedema: a current state-of-the-art review, V: attenuated androgens for the treatment of hereditary angioedema. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[157]  L. Lantieri,et al.  [Can one propose aesthetic surgery to one male or female patient with an hereditary angio-oedema?]. , 2008, Annales de chirurgie plastique et esthetique.

[158]  D. Newby,et al.  Therapeutic potential of icatibant (HOE-140, JE-049). , 2008, Expert opinion on pharmacotherapy.

[159]  J. Vessman,et al.  Pharmacokinetics and bioavailability of tranexamic acid , 2004, European Journal of Clinical Pharmacology.

[160]  Johan Smith,et al.  Case reports and review of the literature , 2003 .

[161]  M. Chappell,et al.  Estrogen regulation of angiotensin-converting enzyme mRNA. , 1999, Hypertension.

[162]  K. Goa,et al.  Tranexamic acid: a review of its use in surgery and other indications. , 1999, Drugs.

[163]  J. Clements,et al.  Localization of bradykinin B2 receptors in the endometrium and myometrium of rat uterus and the effects of estrogen and progesterone. , 1999, Endocrinology.

[164]  M. Feinstein,et al.  [Antiovulatory action of chlormadinone acetate]. , 1994, Contraception, fertilite, sexualite.

[165]  A. Ebert,et al.  [C-1 esterase inhibitor deficiency as an obstetric problem: a case report]. , 1992, Zentralblatt fur Gynakologie.

[166]  J. Jensen,et al.  Hereditary angioneurotic edema in the puerperium. A case report. , 1991, The Journal of reproductive medicine.

[167]  P. Babinet,et al.  [Hereditary angioneurotic edema and pregnancy]. , 1990, Journal de gynecologie, obstetrique et biologie de la reproduction.

[168]  M. Rybojad,et al.  Hereditary angioedema and oral contraception. , 1990, Dermatologica.

[169]  S. Lane,et al.  Immunoblotting of plasma in a pregnant patient with hereditary angioedema. , 1990, The Journal of laboratory and clinical medicine.

[170]  A. Matsumoto,et al.  Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production. , 1990, The Journal of clinical endocrinology and metabolism.

[171]  S. Williams,et al.  Dose-dependent effects of postmenopausal estrogen and progestin on antithrombin III and factor XII. , 1988, The Journal of laboratory and clinical medicine.

[172]  A. Basdevant,et al.  [Progestogen contraception using chlormadinone acetate in women presenting high vascular risk. (A gynecoendocrine, metabolic and vascular study)]. , 1987, Contraception, fertilite, sexualite.

[173]  Dmowski Wp.  Danazol-induced pseudomenopause in the management of endometriosis. , 1987 .

[174]  J. Wautier,et al.  [Norgestrienone, a possible therapeutic agent in hereditary angioneurotic edema]. , 1986, Presse medicale.

[175]  R. Tremblay,et al.  Treatment of hirsutism with spironolactone. , 1986, Clinics in endocrinology and metabolism.

[176]  J. Bonnar,et al.  Effects of tranexamic acid on the coagulation and fibrinolytic systems in pregnancy complicated by placental bleeding. , 1982, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

[177]  R. Barbieri,et al.  Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow-up. , 1982, Fertility and sterility.

[178]  D. Alling,et al.  Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. , 1976, The New England journal of medicine.

[179]  A. Johnston,et al.  Hereditary angioneurotic oedema. , 1973, The Lancet.

[180]  G. Blohmé,et al.  Hereditary angioneurotic oedema in three families. Symptomatic heterogeneity, complement analysis and therapeutic trials. , 1972, Acta medica Scandinavica.